About Virmedex
Virmedex is a company based in Barcelona (Spain) founded in 2022 by Dani Tost, Ariel Von Barnekow, and Nuria Bonet Codina. Virmedex has raised $162.15 thousand across 1 funding round from investors including Grow Venture Partners. Virmedex offers products and services including virCPB, virECMO, and Dex. Virmedex operates in a competitive market with competitors including Fundamental Surgery, Oxford Medical Simulation, Osso VR, SimX and Proximie, among others.
- Headquarter Barcelona, Spain
- Founders Dani Tost, Ariel Von Barnekow, Nuria Bonet Codina
-
Sectors
EducationHealthcare Technology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$162.15 K (USD)
in 1 rounds
-
Latest Funding Round
$162.15 K (USD), Seed
Feb 22, 2024
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Virmedex
Virmedex offers a comprehensive portfolio of products and services, including virCPB, virECMO, and Dex.
Video game for cardiopulmonary bypass training and surgical decision-making.
Immersive game simulating ECMO processes for healthcare skill development.
Chatbot providing real-time support for ECMO and perfusion training.
Funding Insights of Virmedex
Virmedex has successfully raised a total of $162.15K through 1 strategic funding round. The most recent funding activity was a Seed round of $162.15 thousand completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Virmedex
Virmedex has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Grow Venture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Grow Venture Partners is focused on investing in deep tech spin-offs.
|
Locked | Locked | Locked |
Investor details for Virmedex
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Virmedex
Investment portfolio details for Virmedex
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Virmedex
Detailed financials for Virmedex
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Virmedex Comparisons
Peer comparison for Virmedex
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Virmedex
Virmedex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Fundamental Surgery, Oxford Medical Simulation, Osso VR, SimX and Proximie, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-based surgical simulation is enabled via VR and haptics.
|
|
| Locked | Locked | Locked |
VR-based medical training systems are developed for patient care simulations.
|
|
| Locked | Locked | Locked |
Virtual reality platform for surgical training is provided.
|
|
| Locked | Locked | Locked |
Provider of a VR-based medical simulation training platform
|
|
| Locked | Locked | Locked |
Provider of a cloud-based VR platform for surgery guidance
|
|
| Locked | Locked | Locked |
VR-based learning devices for surgeons are provided by apoQlar.
|
Detailed competitors of Virmedex
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Virmedex
Complete news archive for Virmedex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Virmedex
Virmedex was founded in 2022 and raised its 1st funding round 2 years after it was founded.
Virmedex is headquartered in Barcelona, Spain. It is registered at Barcelona, Catalonia, Spain.
Dani Tost is the current CEO of Virmedex. They have also founded this company.
Virmedex is a funded company, having raised a total of $162.15K across 1 funding round to date.
Provider of AR-VR-based training for healthcare professionals. It develops gamified software for specialized training in the medical field. It provides virCPB a platform for cardiopulmonary bypass training designed as a video game.
Virmedex's top competitors include Fundamental Surgery, SimX and Proximie.
Virmedex offers virCPB, virECMO, and Dex.
Virmedex has 1 investor. Key investors include Grow Venture Partners.